Millennium Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $628K | Buy |
174,490
+97,928
| +128% | +$353K | ﹤0.01% | 3246 |
|
2025
Q1 | $229K | Buy |
76,562
+54,056
| +240% | +$162K | ﹤0.01% | 3590 |
|
2024
Q4 | $75.4K | Buy |
+22,506
| New | +$75.4K | ﹤0.01% | 3846 |
|
2024
Q2 | – | Sell |
-212,763
| Closed | -$860K | – | 3963 |
|
2024
Q1 | $860K | Buy |
212,763
+197,163
| +1,264% | +$797K | ﹤0.01% | 3052 |
|
2023
Q4 | $47.6K | Sell |
15,600
-27,784
| -64% | -$84.7K | ﹤0.01% | 3802 |
|
2023
Q3 | $130K | Sell |
43,384
-24,406
| -36% | -$73.2K | ﹤0.01% | 3720 |
|
2023
Q2 | $254K | Sell |
67,790
-4,868
| -7% | -$18.2K | ﹤0.01% | 3612 |
|
2023
Q1 | $243K | Sell |
72,658
-107,028
| -60% | -$358K | ﹤0.01% | 3773 |
|
2022
Q4 | $864K | Buy |
+179,686
| New | +$864K | ﹤0.01% | 3279 |
|
2021
Q4 | – | Sell |
-115,671
| Closed | -$4.06M | – | 5162 |
|
2021
Q3 | $4.06M | Buy |
+115,671
| New | +$4.06M | ﹤0.01% | 2393 |
|
2021
Q2 | – | Sell |
-32,420
| Closed | -$2M | – | 4977 |
|
2021
Q1 | $2M | Buy |
+32,420
| New | +$2M | ﹤0.01% | 2811 |
|